Dragon Pharma Cardiogen 20 mg is supplied as a lyophilized powder in a 2 mL vial and contains the synthetic tetrapeptide Cardiogen at a labeled strength of 20 mg/vial. Product specifications, storage information, and other practical product details are provided below.
20 mg/Vial Strength
Each vial is labeled at 20 mg of Cardiogen peptide.
2 mL Vial
Supplied as a lyophilized powder in a sealed 2 mL vial.
Lyophilized Form
Supplied as a freeze-dried powder for reconstitution with bacteriostatic water or suitable diluent.
Dragon Pharma
Manufactured and packaged under the Dragon Pharma product line.
Product Specifications
Product name
Cardiogen 20 mg
Active substance
Cardiogen
Labeled strength
20 mg/vial
Container
2 mL vial
Product form
Lyophilized powder
Manufacturer
Dragon Pharma
Related Products
Other Khavinson-type peptide bioregulators available from Dragon Pharma include Bronchogen 20 mg, researched for respiratory tissue support, and Livagen 20 mg, researched for liver tissue support. Each has a distinct amino acid sequence and tissue-specific research profile.
Science & Research
Understanding Cardiogen
Cardiogen is a synthetic tetrapeptide composed of four amino acids — alanine, glutamic acid, aspartic acid, and arginine (AEDR). It is classified as a Khavinson-type peptide bioregulator, a class of short peptides known for their potential to interact with chromatin and influence gene expression in a tissue-specific manner.
1
Peptide Bioregulator
Cardiogen is a short tetrapeptide (AEDR) classified as a Khavinson-type peptide bioregulator, designed to influence cellular function in cardiac tissue.
2
Gene Expression Modulation
Khavinson-type peptides are researched for their potential to interact with chromatin and influence gene expression in a tissue-specific manner.
3
Cardiac Research Focus
Cardiogen is specifically researched for its potential to support heart tissue repair, cellular survival, and fibroblast activity regulation.
Mechanism of Action
Cardiogen is a synthetic tetrapeptide (Ala-Glu-Asp-Arg) that belongs to the Khavinson class of peptide bioregulators. These short peptides are characterized by their small size and potential to interact with chromatin, influencing gene expression at the transcriptional level through epigenetic mechanisms.
Khavinson-type peptides are named after the researcher who developed them and are the subject of ongoing investigation into their potential to support tissue-specific functions. Cardiogen's amino acid sequence is specifically associated with research into cardiac tissue support, including cellular survival pathways and fibroblast activity.
Research Context
Cardiogen is researched for its potential to support heart tissue repair through mechanisms involving cellular survival and the regulation of fibroblast activity. These areas of investigation are part of broader research into peptide bioregulators and their potential applications in cardiovascular health.
Dragon Pharma Cardiogen 20 mg is supplied as a lyophilized powder in a 2 mL vial at a labeled strength of 20 mg/vial.
Research References
Cardiogen and related Khavinson-type peptides have been the subject of preclinical research investigating their properties and potential applications.
Cardiogen is a research peptide with limited safety data in humans. As a peptide bioregulator that may influence gene expression and cellular function in cardiac tissue, its use requires appropriate consideration of potential physiological effects.
Cardiovascular Considerations
Cardiogen is researched for its effects on cardiac tissue. Individuals with pre-existing cardiovascular conditions should exercise caution.
Injection Site Reactions
Reconstituted peptides may cause localized reactions at the injection site. Proper aseptic technique is essential for preparation and administration.
Gene Expression Effects
As a peptide bioregulator, Cardiogen may influence gene expression through chromatin interaction. The full scope of these effects is not fully characterized.
Pregnancy and Breastfeeding
Cardiogen is not indicated for use during pregnancy or breastfeeding. Its effects on fetal development and infant health are not established.
Conditions That Require Medical Review
Medical advice is particularly important when there is a history of cardiovascular disease, blood pressure abnormalities, or when taking medications that may interact with cardiac pathways.
The product should also be stored securely to prevent accidental access or use by children or other household members.
When to Seek Urgent Medical Help
Seek urgent medical attention for symptoms such as severe allergic reactions, chest pain, sudden shortness of breath, palpitations, fainting, or signs of a serious adverse reaction.
Tested Sport
Cardiogen is not currently listed on the WADA Prohibited List. However, the use of peptides and research compounds may be subject to specific anti-doping rules depending on the sport and governing body. Current requirements should be checked against the relevant anti-doping rules before competition.
Quick answers about Cardiogen 20 mg specifications, storage, shipping, Bitcoin payment and general product information.
What is Dragon Pharma Cardiogen 20 mg?
Dragon Pharma Cardiogen 20 mg is a lyophilized peptide product containing Cardiogen at a labeled strength of 20 mg per vial. It is supplied in a 2 mL vial as a freeze-dried powder.
What is Cardiogen?
Cardiogen is a synthetic tetrapeptide (Ala-Glu-Asp-Arg, or AEDR) belonging to the Khavinson class of peptide bioregulators. It is researched for its potential to interact with chromatin and influence gene expression related to cardiac tissue repair and cellular survival.
How is Cardiogen 20 mg supplied?
It is supplied as a lyophilized powder in a 2 mL vial. The product must be reconstituted with a suitable diluent such as bacteriostatic water before use in a research setting.
What is a Khavinson-type peptide bioregulator?
Khavinson-type peptide bioregulators are short synthetic peptides (typically 2-4 amino acids) that are researched for their potential to interact with chromatin and influence gene expression in a tissue-specific manner. They are named after the researcher who developed them.
Is Cardiogen 20 mg FDA approved?
No. Cardiogen is not FDA-approved for any therapeutic use. It is a research compound intended for laboratory and preclinical research purposes only.
How should Cardiogen 20 mg be stored?
Keep the lyophilized powder in its original packaging and protect it from excessive heat, moisture and direct light. Refer to the product label for specific storage directions regarding temperature and shelf life. Once reconstituted, the solution should be used promptly or stored according to the manufacturer's directions.
Does Cardiogen 20 mg require refrigeration?
Follow the storage instructions printed on the supplied product. Lyophilized peptides often require refrigeration, but specific storage conditions should be verified from the product label.
How long does Cardiogen 20 mg delivery take?
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Can I buy Cardiogen 20 mg with Bitcoin?
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy Cardiogen 20 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Is Bitcoin payment anonymous?
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
Is Cardiogen permitted in tested sport?
Cardiogen is not currently listed on the WADA Prohibited List. However, the use of peptides and research compounds may be subject to specific anti-doping rules depending on the sport and governing body. Current requirements should be checked against the relevant anti-doping rules before competition.
Where can I find more information about Cardiogen?
Additional information about Cardiogen and Khavinson-type peptides is available through PubMed and other research literature databases. Direct links are provided in the Science & Research section above.
